Heparan sulphate

glycosaminoglycan

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Link	Tested on	Impact factor	Notes	Publication date
Glycosaminoglycans induce conformational change in the SARS-CoV-2 Spike S1 Receptor Binding Domain. Spike protein Preprint	in vitro			Apr/29/2020
SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner Spike protein Preprint	in vitro			May/10/2020

Link	Publication date
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.	Jun/07/2021